Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

6.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.2K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

842
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
842

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuroendocrine Tumors: Beta Labeled Radiopeptides.

PET clinics·2025
Same author

Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [<sup>177</sup>Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer.

European journal of nuclear medicine and molecular imaging·2024
Same author

ACR-ACNM-ARS-ASTRO-SNMMI Practice Parameter for the Performance of Therapy With Radiopharmaceuticals.

American journal of clinical oncology·2023
Same author

SPECT at the speed of PET: a feasibility study of CZT-based whole-body SPECT/CT in the post <sup>177</sup>Lu-DOTATATE and <sup>177</sup>Lu-PSMA617 setting.

European journal of nuclear medicine and molecular imaging·2023
Same author

Atypical Polycystic Kidney Disease as defined by Imaging.

Scientific reports·2023
Same author

A Pilot Study of <sup>68</sup>Ga-PSMA11 and <sup>68</sup>Ga-RM2 PET/MRI for Biopsy Guidance in Patients with Suspected Prostate Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2022

Related Experiment Video

Updated: Apr 23, 2026

Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain
06:31

Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain

Published on: August 8, 2019

6.3K

Normal SUV values measured from NaF18- PET/CT bone scan studies.

Aung Zaw Win1, Carina Mari Aparici2

  • 1Department of Radiology, San Francisco VA Medical Center, San Francisco, California, United States of America.

Plos One
|September 26, 2014
PubMed
Summary
This summary is machine-generated.

This study established normal Standardized Uptake Values (SUV) for healthy skeletons using Sodium Fluoride F-18 PET/CT scans. These reference values are crucial for diagnosing bone conditions and assessing treatment effectiveness.

More Related Videos

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Published on: October 4, 2024

1.0K
Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

14.9K

Related Experiment Videos

Last Updated: Apr 23, 2026

Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain
06:31

Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain

Published on: August 8, 2019

6.3K
Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Published on: October 4, 2024

1.0K
Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

14.9K

Area of Science:

  • Nuclear Medicine
  • Radiology
  • Oncology

Background:

  • Standardized Uptake Values (SUV) in Sodium Fluoride F-18 Positron Emission Tomography/Computed Tomography (NaF-18 PET/CT) bone scans can be affected by cancer and metabolic bone diseases.
  • Establishing normal SUV ranges in healthy individuals is essential for accurate interpretation of bone scans.

Purpose of the Study:

  • To determine the normal Standardized Uptake Values (SUV) in various skeletal sites of healthy individuals using NaF-18 PET/CT bone scans.
  • To provide a baseline for comparison with SUV values in patients with bone pathologies.

Main Methods:

  • A retrospective analysis of NaF-18 PET/CT bone scans performed between January 2010 and May 2012.
  • Inclusion criteria focused on patients without a history of cancer or metabolic bone diseases and with normal renal function.
  • Eleven studies met the selection criteria for analysis.

Main Results:

  • Average normal SUVmax values were recorded for different skeletal locations.
  • Cervical vertebrae: 6.84, Thoracic vertebrae: 7.36, Lumbar vertebrae: 7.27.
  • Other sites included femoral head (2.22), humeral head (1.82), sternum (5.51), and parietal bone (1.71).

Conclusions:

  • Significant variations in normal SUV values exist across different skeletal sites.
  • Known normal SUV ranges aid in differentiating healthy bone from bone affected by tumors or metabolic diseases.
  • SUV quantification in NaF-18 PET/CT studies is valuable for characterizing bone lesions and monitoring treatment response.